References
- de Bolle L, Naesens L, de Clercq E. Update on human herpes virus 6 biology, clinical features, and therapy. Clin Microbiol Reviews 2005; 18: 217–45
- Yoshikawa T, Asano Y, Ihira M, Suzuki K, Ohashi M, Suga S, et al. Human herpes virus 6 viremia in bone marrow transplant recipients: clinical features and risk factors. J Infect Dis 2002; 185: 847–53
- Ljungman P, Wang FZ, Clark DA, Emery VC, Remberger M, Ringden O, et al. High levels of human herpes virus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol 2000; 111: 774–81
- Drobyski WR, Knox KK, Majewski D, Carrigan DR. Fatal encephalitis due to variant B human herpes virus-6 infection in a bone marrow transplant recipient. N Engl J Med 1994; 330: 1356–60
- Wang FZ, Linde A, Hagglund H, Testa M, Locasciulli A, Ljungman P. Human herpes virus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance?. Clin Infect Dis 1998; 28: 562–8
- Cole PD, Stiles J, Boulad F, Small TN, O'Reilly RJ, George D, et al. Successful treatment of human herpes virus 6 encephalitis in a bone marrow transplantation recipient. Clin Infect Dis 1998; 27: 653–4
- Mookerjee BP, Vogelsang G. Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with gancyclovir. Bone Marrow Transplant 1997; 20: 905–6
- Sashihara J, Tanaka-Taya K, Tanaka S, Amo K, Miyagawa H, Hosoi G, et al. High incidence of human herpes virus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 2002; 100: 2005–11
- Hill AE, Hicks EM, Coyle PV. Human herpes virus 6 and central nervous system complications. Dev Med Child Neurol 1994; 36: 651–2